InvestorsHub Logo
Followers 208
Posts 18604
Boards Moderated 0
Alias Born 11/10/2012

Re: Investaholic33 post# 38764

Monday, 03/27/2017 2:55:23 PM

Monday, March 27, 2017 2:55:23 PM

Post# of 106844
It’s lead development asset, what it’s calling MyoCell, is reportedly about to pick up fast track designation, and the development pathway that follows should bring with it numerous catalysts that – in turn – should draw speculative volume towards US Stem Cell.

The posts contained on this account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.